Breaking the “Black Box” in Bioprocessing
Why understanding titer analytics is key to faster, more reliable biologics and gene therapy development
False
Why understanding titer analytics is key to faster, more reliable biologics and gene therapy development
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.
False
False
December 1, 2014
0 min read
Upstream processes in biopharma manufacturing are growing ever more efficient; conversely, downstream processing is increasingly a bottleneck. Can a new generation of chromatography techniques and technologies get things moving again?
April 2, 2025
5 min read
Off-the-shelf allogeneic CAR-Ts, increased manufacturing productivity led by digital systems, and more; we ask experts about the future of advanced medicine.
April 7, 2025
6 min read
Meet one company and its new drug candidate in the fight against gram-negative bacterial infections.
March 3, 2025
5 min read
From the GSK boardroom to the White House, and now the board of Abzena, the career path of Moncef Slaoui has resulted in billions of doses of lifesaving vaccines. Here he shares his story.
False
Affiliations:
Specialties:
Areas of Expertise: